carvedilol has been researched along with cardiovascular agents in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL | 1 |
| Cheng, J; Kamiya, K; Kodama, I | 1 |
| Alexy, T; Battyany, I; Halmosi, R; Hideg, K; Horvath, B; Kesmarky, G; Marton, Z; Toth, K; Vekasi, J | 1 |
| Taccetta-Chapnick, M | 1 |
| Asano, R; Hosoda, S; Kitahara, K; Misu, K; Nagayama, M; Ohtaki, E; Sumiyoshi, T; Takeda, N; Tobaru, T; Umemura, J | 1 |
| Amann-Zalan, I; Castaigne, A; Coats, AJ; Fowler, MB; Hartmann, F; Hoersch, S; Katus, HA; Krum, H; Mohacsi, P; Packer, M; Rouleau, JL; Tendera, M; Trawinski, J | 1 |
| Fyhrquist, F; Nyman, T; Saijonmaa, O | 1 |
| Amann-Zalan, I; Anker, SD; Castaigne, A; Coats, AJ; Fowler, MB; Hartmann, F; Hoersch, S; Katus, HA; Krum, H; Mohacsi, P; Packer, M; Rouleau, JL; Tendera, M | 1 |
| Nordling, MK | 1 |
| Cíz, M; Gallova, L; Holománová, D; Lojek, A; Macicková, T; Nosál', R; Pecivová, J | 1 |
| Ingber, A; Moshe, S; Neumark, M; Slodownik, D | 1 |
| Bandyopadhyay, S; Kapil, R; Katare, OO; Khurana, L; Singh, B | 1 |
| Bagriy, AE; Bagriy, EA; Malovichko, SI; Pricolota, AV; Pricolota, OA; Samoilova, OV; Schukina, EV | 1 |
| Bocchi, EA; Böhm, M; Borer, JS; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Akabuogu, EU; Phyu, SM; Smith, TA | 1 |
| Khalil, F; Läer, S; Rasool, MF | 1 |
| Al-Saadi, T; Al-Zakwani, I; Alshekaili, L; Sallam, M | 1 |
| Beck, RC; Chaves, PD; Frank, LA; Guterres, SS; Ourique, AF; Pohlmann, AR | 1 |
| Baghyari, S; Esmaili, K; Janbabai, G; Nabati, M; Yazdani, J | 1 |
| Balmer, C; Caduff Good, A; Cavigelli, A; Klauwer, D; Moser-Bracher, A; Satir, A | 1 |
| Guang-Yi, C; Li-Sha, G; Yue-Chun, L | 1 |
| Dickens, C; Dix-Peek, T; Duarte, R; Grinter, S; Hale, M; Janssens, S; Manga, P; McCutcheon, K; McCutcheon, L; Patel, A; Tsabedze, N; Vachiat, A; van Pelt, J; Zachariah, D | 1 |
| Isenmen, H; Jones, L | 1 |
| Castagnetti, V; Palazzoli, F; Profeta, C; Santunione, AL; Silingardi, E; Vandelli, D; Verri, P | 1 |
3 review(s) available for carvedilol and cardiovascular agents
| Article | Year |
|---|---|
Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Antioxidants; Blood Glucose; Carbazoles; Cardiovascular Agents; Cardiovascular System; Carvedilol; Heart Conduction System; Heart Failure; Humans; Hypertension; Lipids; Myocardial Ischemia; Neurotransmitter Agents; Propanolamines | 2001 |
Using carvedilol to treat heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiovascular Agents; Carvedilol; Diuretics; Drug Interactions; Heart Failure; Humans; Propanolamines; Treatment Outcome | 2002 |
Role of Heart Rate Reduction in the Management of Myocarditis.
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Carvedilol; Heart Rate; Humans; Inflammation; Ivabradine; Myocarditis | 2018 |
6 trial(s) available for carvedilol and cardiovascular agents
| Article | Year |
|---|---|
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
Topics: Aged; Biomarkers; Carbazoles; Cardiovascular Agents; Carvedilol; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Prognosis; Propanolamines; Prospective Studies; Stroke Volume | 2004 |
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Topics: Adrenergic beta-Antagonists; Aged; Biomarkers; Blood Pressure; Carbazoles; Cardiovascular Agents; Carvedilol; Creatinine; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Life Tables; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Prognosis; Propanolamines; Proportional Hazards Models; Prospective Studies; Stroke Volume; Survival Analysis | 2004 |
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Proportional Hazards Models; Treatment Outcome | 2015 |
Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure.
Topics: Adrenergic Antagonists; Aged; Benzazepines; Carbazoles; Cardiovascular Agents; Carvedilol; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Oman; Propanolamines; Prospective Studies; Quality of Life; Stroke Volume; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ventricular Function, Left | 2016 |
Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Atrial Function, Left; Biomarkers; Breast Neoplasms; Carbazoles; Cardiotoxicity; Cardiovascular Agents; Carvedilol; Echocardiography, Doppler, Pulsed; Female; Heart Diseases; Humans; Iran; Middle Aged; Propanolamines; Risk Assessment; Risk Factors; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Troponin I; Ventricular Function, Left; Young Adult | 2017 |
Dynamic Changes in the Molecular Signature of Adverse Left Ventricular Remodeling in Patients With Compensated and Decompensated Chronic Primary Mitral Regurgitation.
Topics: Adult; Cardiovascular Agents; Carvedilol; Chronic Disease; Gene Expression Profiling; Humans; Middle Aged; Mitral Valve Insufficiency; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2019 |
15 other study(ies) available for carvedilol and cardiovascular agents
| Article | Year |
|---|---|
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Ischemia; Myocardium; Peroxidase; Propanolamines; Rabbits; Reperfusion Injury; Ventricular Pressure | 2000 |
Scavenger effect of experimental and clinically used cardiovascular drugs.
Topics: Anti-Arrhythmia Agents; Antioxidants; Carbazoles; Cardiovascular Agents; Carvedilol; Erythrocytes; Free Radical Scavengers; Humans; Indoles; Male; Methylphenazonium Methosulfate; Mexiletine; Propanolamines; Pyrroles; Sotalol | 2001 |
Normalization of left ventricular parameters following combined pimobendan and carvedilol treatment in a case of unclassified cardiomyopathy with longstanding refractory status.
Topics: Carbazoles; Cardiomyopathies; Cardiovascular Agents; Carvedilol; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Pyridazines; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2002 |
Carvedilol inhibits basal and stimulated ACE production in human endothelial cells.
Topics: Carbazoles; Cardiovascular Agents; Carvedilol; Cells, Cultured; Endothelium, Vascular; Humans; Immunoblotting; Peptidyl-Dipeptidase A; Phosphorylation; Propanolamines; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Umbilical Veins; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2004 |
Estimating mortality reduction by comparing survival curves.
Topics: Carbazoles; Cardiovascular Agents; Carvedilol; Computer Simulation; Evidence-Based Medicine; Heart Failure; Humans; Metoprolol; Propanolamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Survival Rate; Time Factors | 2004 |
In vitro effect of carvedilol on professional phagocytes.
Topics: Androstadienes; Animals; Blotting, Western; Carbazoles; Cardiovascular Agents; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Humans; Luminescence; Male; Mice; N-Formylmethionine Leucyl-Phenylalanine; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Phagocytes; Propanolamines; Spectrophotometry; Superoxides; Wortmannin | 2007 |
Occupational airborne contact dermatitis to simvastatin, carvedilol, and zolpidem.
Topics: Adult; Air Pollutants, Occupational; Carbazoles; Cardiovascular Agents; Carvedilol; Dermatitis, Occupational; Humans; Hypnotics and Sedatives; Male; Propanolamines; Pyridines; Simvastatin; Zolpidem | 2009 |
Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
Topics: Animals; Biological Availability; Caprylates; Carbazoles; Cardiovascular Agents; Carvedilol; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Emulsions; Ethylene Glycols; Excipients; Glycerides; Glycerol; Intestinal Absorption; Jejunum; Male; Microscopy, Electron, Transmission; Nanostructures; Oils; Particle Size; Perfusion; Propanolamines; Rats; Rats, Wistar; Solubility | 2011 |
Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Carbazoles; Cardiovascular Agents; Carvedilol; Drug Therapy, Combination; Exercise; Exercise Tolerance; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left | 2015 |
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Carvedilol; Cell Line, Tumor; Cell Survival; Dexrazoxane; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Enalapril; Female; Fluorodeoxyglucose F18; Humans; Metformin; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab | 2016 |
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Biological Availability; Biotransformation; Carbazoles; Cardiovascular Agents; Carvedilol; Child; Child, Preschool; Chronic Disease; Female; Heart Failure; Humans; Infant; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Propanolamines; Regional Blood Flow; Stereoisomerism; Young Adult | 2016 |
Carvedilol-loaded nanocapsules: Mucoadhesive properties and permeability across the sublingual mucosa.
Topics: Acrylic Resins; Administration, Sublingual; Animals; Carbazoles; Cardiovascular Agents; Carvedilol; Delayed-Action Preparations; Drug Compounding; Excipients; In Vitro Techniques; Mouth Mucosa; Nanocapsules; Permeability; Polyesters; Polymethacrylic Acids; Propanolamines; Swine; Tissue Adhesives | 2017 |
Digoxin Toxicity in a Neonate Caused by the Interaction with Carvedilol.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Carvedilol; Digoxin; Disease Progression; Heart Failure; Humans; Infant, Newborn | 2017 |
Not the usual suspects: DRESS secondary to carvedilol.
Topics: Aged; Cardiovascular Agents; Carvedilol; Drug Hypersensitivity Syndrome; Female; Humans; New Zealand; Ventricular Dysfunction, Left | 2020 |
Cardiovascular drugs and suicide death: Determination of carvedilol, amlodipine, doxazosin and diltiazem in two fatal cases.
Topics: Amlodipine; Cardiovascular Agents; Carvedilol; Diltiazem; Doxazosin; Humans; Suicide | 2024 |